86.90.E - Other human health activities notelsewhere classified
46.46.Z - Wholesale of pharmaceutical goods
68.20.Z - Rental and operating of own or leased real estate
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
78.10.Z - Activities of employment placement agencies
78.30.Z - Other human resources provision
86.10.Z - Hospital activities
86.90.B - Emergency ambulance activities
86.90.D - Paramedical activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,4 | -0,6 | 0,4 | 159,6 |
EBITDA | 0,8 | -0,1 | 1 | 2009,8 |
Short time liabilities | 1,1 | 1,5 | 1,5 | 1,9 |
Equity capital | 4,6 | 3,9 | 4,3 | 10,1 |
Operating profit (EBIT) | 0,5 | -0,5 | 0,5 | 204,1 |
Assets | 6,6 | 7 | 7,3 | 3,9 |
Net profit (loss) | 0,4 | -0,6 | 0,4 | 159,6 |
Cash | 4,7 | 2,7 | 0,4 | -86,6 |
Net income from sale | 11 | 11,1 | 12,3 | 10,4 |
Liabilities and provisions for liabilities | 2 | 3 | 2,9 | -4,2 |
Working assets | 5,5 | 4 | 1,8 | -54,1 |
Depreciation | 0,3 | 0,4 | 0,5 | 24,8 |
% | % | % | p.p. | |
Profitability of capital | 9 | -15 | 8,1 | 23,1 |
Equity capital to total assets | 69,1 | 56,4 | 59,8 | 3,4 |
Gross profit margin | 3,8 | -5,3 | 2,9 | 8,2 |
EBITDA Margin | 7,4 | -0,5 | 8,4 | 8,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 35 | 48 | 44 | -4 |
Current financial liquidity indicator | 5.13944673538208 | 2.704270839691162 | 1.2187299728393555 | -1,5 |
Net dept to EBITDA | -4.625113010406494 | 20.621627807617188 | 1.022383689880371 | -19,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane